Microtubule inhibitors, anthracyclines and topoisomerase inhibitors
How vinca alkaloids and taxanes disrupt the mitotic spindle, how topoisomerase poisons turn transient DNA breaks into lethal ones, why irinotecan toxicity depends on UGT1A1, and how anthracycline cardiotoxicity relates to cumulative dose and is monitored under the ESC cardio-oncology guideline.
Tier 2Medical sciences concept
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- Microtubule inhibitors (vinca alkaloids, taxanes, eribulin) disrupt the mitotic spindle and arrest cells in M phase. Microtubules also carry axonal transport, so peripheral neuropathy is the class toxicity.
- Topoisomerase poisons trap the enzyme on DNA after it has cut. Topoisomerase I inhibitors leave single-strand breaks; topoisomerase II inhibitors leave double-strand breaks.
- Anthracyclines intercalate into DNA, poison topoisomerase II and generate iron-dependent free radicals. Cumulative dose-dependent cardiomyopathy is the exam topic.
Loading the rest of the note…
Finished reading?
Sources
- eviQ cancer treatments onlineAU/NZCancer Institute NSW, 2026
- Australian Medicines HandbookAU/NZAustralian Medicines Handbook Pty Ltd, 2026
- 2022 ESC Guidelines on cardio-oncology (Lyon et al.)European Heart Journal 2022;43:4229-361, 2022
- Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials (Swain et al.)Cancer 2003;97:2869-79, 2003
- Goodman & Gilman's The Pharmacological Basis of Therapeutics (14th ed.)McGraw Hill (Brunton and Knollmann, 2023), 2023
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback